SUpPress SSI - Single Use Negative Pressure Wound Therapy (NPWT) to Reduce Surgical Site Infections (SUpPressSSI)
Sponsor: Acelity
Listed as NCT03816293, this NA trial focuses on Cesarean Section Complications and Diabetes and remains completed. Sponsored by Acelity, it has been updated 10 times since 2019, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Dec 2022 — Jul 2024 [monthly]
Completed NA
Status: Enrolling By Invitation → Completed
-
Mar 2021 — Dec 2022 [monthly]
Enrolling By Invitation NA
-
Jan 2021 — Mar 2021 [monthly]
Enrolling By Invitation NA
▶ Show 5 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Enrolling By Invitation NA
-
Nov 2019 — Feb 2020 [monthly]
Enrolling By Invitation NA
Status: Not Yet Recruiting → Enrolling By Invitation
-
Sep 2019 — Nov 2019 [monthly]
Not Yet Recruiting NA
-
May 2019 — Sep 2019 [monthly]
Not Yet Recruiting NA
-
Feb 2019 — May 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Acelity
- Centers for Disease Control and Prevention
- Emory University
- University of Illinois at Chicago
- University of Iowa
- University of Maryland
For direct contact, visit the study record on ClinicalTrials.gov .